To optimise synthetic IFNA14 derivatives for immune cell activation and cancer cell growth suppression

优化用于免疫细胞激活和癌细胞生长抑制的合成 IFNA14 衍生物

• 批准号: BB/V509218/1
• 金额: $ 13.48万
• 依托单位: University of Edinburgh
• 依托单位国家: 英国
• 项目类别: Training Grant
• 财政年份: 2021
• 资助国家: 英国
• 起止时间: 2021 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=BB%2FV509218%2F1
• 关键词: optimise; synthetic; IFNA14; derivatives; immune

Doctoral Training Partnerships: a range of postgraduate training is funded by the Research Councils. For information on current funding routes, see the common terminology at https://www.ukri.org/apply-for-funding/how-we-fund-studentships/. Training grants may be to one organisation or to a consortia of research organisations. This portal will show the lead organisation only.

博士培训伙伴关系：一系列研究生培训由研究理事会资助。有关当前融资途径的信息，请参阅https://www.ukri.org/apply-for-funding/how-we-fund-studentships/上的通用术语。培训赠款可以提供给一个组织或一个研究组织联合体。该门户网站将只显示牵头组织。